125 related articles for article (PubMed ID: 26291712)
1. Disseminated Enteroviral Infection Associated with Obinutuzumab.
Dendle C; Gilbertson M; Korman TM; Golder V; Morand E; Opat S
Emerg Infect Dis; 2015 Sep; 21(9):1661-3. PubMed ID: 26291712
[TBL] [Abstract][Full Text] [Related]
2. Disseminated enterovirus infection in a patient treated with obinutuzumab.
McNeil T; Hannah R; Hui CH; Qiao M
J Med Virol; 2022 Feb; 94(2):439-441. PubMed ID: 34590740
[No Abstract] [Full Text] [Related]
3. Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy.
Heger JM; Eichenauer DA; Kasper P; Böll B; Shimabukuro-Vornhagen A; Kochanek M
Eur J Haematol; 2019 Sep; 103(3):268-271. PubMed ID: 31211882
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013.
Eyckmans T; Wollants E; Janssens A; Schoemans H; Lagrou K; Wauters J; Maertens J
Emerg Infect Dis; 2014 May; 20(5):913-5. PubMed ID: 24751368
[No Abstract] [Full Text] [Related]
5. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.
Ganjoo KN; Raman R; Sobel RA; Pinto HA
Leuk Lymphoma; 2009 Apr; 50(4):673-5. PubMed ID: 19373672
[No Abstract] [Full Text] [Related]
6. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
Servais S; Caers J; Warling O; Frusch N; Baron F; De Prijck B; Beguin Y
Br J Haematol; 2010 Aug; 150(3):379-81. PubMed ID: 20408837
[No Abstract] [Full Text] [Related]
7. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
Quartier P; Tournilhac O; Archimbaud C; Lazaro L; Chaleteix C; Millet P; Peigue-Lafeuille H; Blanche S; Fischer A; Casanova JL; Travade P; Tardieu M
Clin Infect Dis; 2003 Feb; 36(3):e47-9. PubMed ID: 12539090
[TBL] [Abstract][Full Text] [Related]
8. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients.
McKinney RE; Katz SL; Wilfert CM
Rev Infect Dis; 1987; 9(2):334-56. PubMed ID: 3296100
[TBL] [Abstract][Full Text] [Related]
9. Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab.
Padate BP; Keidan J
Clin Lab Haematol; 2006 Feb; 28(1):69-71. PubMed ID: 16430465
[TBL] [Abstract][Full Text] [Related]
10. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
Schilthuizen C; Berenschot HW; Levin MD
Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus infection of neuronal cells post-Rituximab.
Kiani-Alikhan S; Skoulidis F; Barroso A; Nuovo G; Ushiro-Lumb I; Breuer J; Lister A; Mattes F
Br J Haematol; 2009 Aug; 146(3):333-5. PubMed ID: 19466969
[No Abstract] [Full Text] [Related]
12. Enterovirus 71 meningoencephalitis during chemotherapy in a child with metastatic osteosarcoma.
Frange P; Michon J; Fromantin I; Franck N; Safar E; Escande MC; Desguerre I; Orbach D
J Pediatr Hematol Oncol; 2007 Aug; 29(8):566-8. PubMed ID: 17762499
[TBL] [Abstract][Full Text] [Related]
13. Obinutuzumab for chronic lymphocytic leukemia.
Rioufol C; Salles G
Expert Rev Hematol; 2014 Oct; 7(5):533-43. PubMed ID: 25163491
[TBL] [Abstract][Full Text] [Related]
14. Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies.
Martin de Frémont G; Chabrolles H; Mirand A; L'Honneur AS; Mélé N; Dunogue B; Boutboul D; Farhat M; Hachulla E; Lazrek M; Rieu V; Mathian A; Chaussade H; Ruet A; Burrel S; Coury-Lucas F; Schuffenecker I; Lemaignen A; Stefic K; le Besnerais M; Carrette M; Mouthon L; Avettand-Fenoel V; Terrier B; Hadjadj J
RMD Open; 2024 May; 10(2):. PubMed ID: 38772678
[TBL] [Abstract][Full Text] [Related]
15. Neonatal enteroviral sepsis/meningoencephalitis and hemophagocytic lymphohistiocytosis: diagnostic challenges.
Lindamood KE; Fleck P; Narla A; Vergilio JA; Degar BA; Baldwin M; Wintermark P
Am J Perinatol; 2011 May; 28(5):337-46. PubMed ID: 21089006
[TBL] [Abstract][Full Text] [Related]
16. Enteroviral meningoencephalitis in an infant: an increasingly recognised infection.
Oades PJ; Ladhani S
Arch Dis Child; 2015 Feb; 100(2):208. PubMed ID: 25246091
[No Abstract] [Full Text] [Related]
17. Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study.
Morschhauser FA; Cartron G; Thieblemont C; Solal-Céligny P; Haioun C; Bouabdallah R; Feugier P; Bouabdallah K; Asikanius E; Lei G; Wenger M; Wassner-Fritsch E; Salles GA
J Clin Oncol; 2013 Aug; 31(23):2912-9. PubMed ID: 23835718
[TBL] [Abstract][Full Text] [Related]
18. Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibody.
Goede V; Klein C; Stilgenbauer S
Oncol Res Treat; 2015; 38(4):185-92. PubMed ID: 25877943
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus 71 meningoencephalitis complicating rituximab therapy.
Ahmed R; Buckland M; Davies L; Halmagyi GM; Rogers SL; Oberste S; Barnett MH
J Neurol Sci; 2011 Jun; 305(1-2):149-51. PubMed ID: 21444094
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Enterovirus Infection in a Patient Affected by Follicular Lymphoma Treated with Obinutuzumab: A Case Report and a Narrative Review of the Literature.
Lupia T; Corcione S; Staffilano E; Bosio R; Curtoni A; Busca A; De Rosa FG
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
